natgillin/translations-raw huggingface dataset:
Binocrit 1,000 IU/0.5 ml solution for injection in a pre-filled syringe Binocrit 2,000 IU/1 ml solution for injection in a pre-filled syringe Binocrit 3,000 IU/0.3 ml solution for injection in a pre-filled syringe Binocrit 4,000 IU/0.4 ml solution for injection in a pre-filled syringe Binocrit 5,000 IU/0.5 ml solution for injection in a pre-filled syringe Binocrit 6,000 IU/0.6 ml solution for injection in a pre-filled syringe Binocrit 7,000 IU/0.7 ml solution for injection in a pre-filled syringe Binocrit 8,000 IU/0.8 ml solution for injection in a pre-filled syringe Binocrit 9,000 IU/0.9 ml solution for injection in a pre-filled syringe Binocrit 10,000 IU/1 ml solution for injection in a pre-filled syringe Binocrit 20,000 IU/0.5 ml solution for injection in a pre-filled syringe Binocrit 30,000 IU/0.75 ml solution for injection in a pre-filled syringe Binocrit 40,000 IU/1 ml solution for injection in a pre-filled syringe
Binocrit 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 1,000 IU/0.5 ml solution for injection in a pre-filled syringe Each syringe contains 0.5 ml of solution for injection.
Binocrit 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,5 ml otopine za injekciju.
Binocrit 1,000 IU/0.5 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 1,000 IU/0.5 ml solution for injection in a pre-filled syringe EU/1/07/410/001
Binocrit 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/001
Binocrit 10,000 IU/1 ml
Binocrit 10 000 IU/1 ml
Binocrit 10,000 IU/1 ml injection
Binocrit 10 000 IU/1 ml injekcija
Binocrit 10,000 IU/1 ml solution for injection in a pre-filled syringe
Binocrit 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 10,000 IU/1 ml solution for injection in a pre-filled syringe Each syringe contains 1 ml of solution for injection.
Binocrit 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 1 ml otopine za injekciju.
Binocrit 10,000 IU/1 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 10,000 IU/1 ml solution for injection in a pre-filled syringe EU/1/07/410/015
Binocrit 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/015
Binocrit 2,000 IU/1 ml injection
Binocrit 2000 IU/1 ml injekcija
Binocrit 2,000 IU/1 ml solution for injection in a pre-filled syringe
Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 2,000 IU/1 ml solution for injection in a pre-filled syringe Each syringe contains 1 ml of solution for injection.
Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 1 ml otopine za injekciju.
Binocrit 2,000 IU/1 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 2,000 IU/1 ml solution for injection in a pre-filled syringe EU/1/07/410/003
Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/003
Binocrit 20,000 IU/0.5 ml
Binocrit 20 000 IU/0,5 ml
Binocrit 20,000 IU/0.5 ml injection
Binocrit 20 000 IU/0,5 ml injekcija
Binocrit 20,000 IU/0.5 ml solution for injection in a pre-filled syringe
Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 20,000 IU/0.5 ml solution for injection in a pre-filled syringe Each syringe contains 0.5 ml of solution for injection.
Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,5 ml otopine za injekciju.
Binocrit 20,000 IU/0.5 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 20,000 IU/0.5 ml solution for injection in a pre-filled syringe EU/1/07/410/021
Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/021
Binocrit 3,000 IU/0.3 ml injection
Binocrit 3000 IU/0,3 ml injekcija
Binocrit 3,000 IU/0.3 ml solution for injection in a pre-filled syringe
Binocrit 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 3,000 IU/0.3 ml solution for injection in a pre-filled syringe Each syringe contains 0.3 ml of solution for injection.
Binocrit 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,3 ml otopine za injekciju.
Binocrit 3,000 IU/0.3 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 3,000 IU/0.3 ml solution for injection in a pre-filled syringe EU/1/07/410/005
Binocrit 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/005
Binocrit 30,000 IU/0.75 ml
Binocrit 30 000 IU/0,75 ml
Binocrit 30,000 IU/0.75 ml injection
Binocrit 30 000 IU/0,75 ml injekcija
Binocrit 30,000 IU/0.75 ml solution for injection in a pre-filled syringe
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 30,000 IU/0.75 ml solution for injection in a pre-filled syringe Each syringe contains 0.75 ml of solution for injection.
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,75 ml otopine za injekciju.
Binocrit 30,000 IU/0.75 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 30,000 IU/0.75 ml solution for injection in a pre-filled syringe EU/1/07/410/023
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/023
Binocrit 4,000 IU/0.4 ml injection
Binocrit 4000 IU/0,4 ml injekcija
Binocrit 4,000 IU/0.4 ml solution for injection in a pre-filled syringe
Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 4,000 IU/0.4 ml solution for injection in a pre-filled syringe Each syringe contains 0.4 ml of solution for injection.
Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,4 ml otopine za injekciju.
Binocrit 4,000 IU/0.4 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 4,000 IU/0.4 ml solution for injection in a pre-filled syringe EU/1/07/410/007
Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/007
Binocrit 40,000 IU/1 ml
Binocrit 40 000 IU/1 ml
Binocrit 40,000 IU/1 ml injection
Binocrit 40 000 IU/1 ml injekcija
Binocrit 40,000 IU/1 ml solution for injection in a pre-filled syringe
Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 40,000 IU/1 ml solution for injection in a pre-filled syringe Each syringe contains 1 ml of solution for injection.
Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 1 ml otopine za injekciju.
Binocrit 40,000 IU/1 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 40,000 IU/1 ml solution for injection in a pre-filled syringe EU/1/07/410/025
Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/025
Binocrit 5,000 IU/0.5 ml injection
Binocrit 5000 IU/0,5 ml injekcija
Binocrit 5,000 IU/0.5 ml solution for injection in a pre-filled syringe
Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 5,000 IU/0.5 ml solution for injection in a pre-filled syringe Each syringe contains 0.5 ml of solution for injection.
Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,5 ml otopine za injekciju.
Binocrit 5,000 IU/0.5 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 5,000 IU/0.5 ml solution for injection in a pre-filled syringe EU/1/07/410/009
Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/009
Binocrit 6,000 IU/0.6 ml injection
Binocrit 6000 IU/0,6 ml injekcija
Binocrit 6,000 IU/0.6 ml solution for injection in a pre-filled syringe
Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 6,000 IU/0.6 ml solution for injection in a pre-filled syringe Each syringe contains 0.6 ml of solution for injection.
Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,6 ml otopine za injekciju.
Binocrit 6,000 IU/0.6 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 6,000 IU/0.6 ml solution for injection in a pre-filled syringe EU/1/07/410/011
Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/011
Binocrit 7,000 IU/0.7 ml injection
Binocrit 7000 IU/0,7 ml injekcija
Binocrit 7,000 IU/0.7 ml solution for injection in a pre-filled syringe
Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 7,000 IU/0.7 ml solution for injection in a pre-filled syringe Each syringe contains 0.7 ml of solution for injection.
Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,7 ml otopine za injekciju.
Binocrit 7,000 IU/0.7 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 7,000 IU/0.7 ml solution for injection in a pre-filled syringe EU/1/07/410/017
Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/017
Binocrit 8,000 IU/0.8 ml injection
Binocrit 8000 IU/0,8 ml injekcija
Binocrit 8,000 IU/0.8 ml solution for injection in a pre-filled syringe
Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 8,000 IU/0.8 ml solution for injection in a pre-filled syringe Each syringe contains 0.8 ml of solution for injection.
Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,8 ml otopine za injekciju.
Binocrit 8,000 IU/0.8 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 8,000 IU/0.8 ml solution for injection in a pre-filled syringe EU/1/07/410/013
Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/013
Binocrit 9,000 IU/0.9 ml injection
Binocrit 9000 IU/0,9 ml injekcija
Binocrit 9,000 IU/0.9 ml solution for injection in a pre-filled syringe
Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki
Binocrit 9,000 IU/0.9 ml solution for injection in a pre-filled syringe Each syringe contains 0.9 ml of solution for injection.
Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,9 ml otopine za injekciju.
Binocrit 9,000 IU/0.9 ml solution for injection in a pre-filled syringe Epoetin alfa
Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 9,000 IU/0.9 ml solution for injection in a pre-filled syringe EU/1/07/410/019
Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/019
Binocrit contains less than 1 mmol sodium (23 mg) per dose i.e. essentially “sodium free”.
Binocrit sadrži manje od 1 mmol natrija (23 mg) po dozi, tj. zanemarive količine natrija.
Binocrit contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen).
Binocrit sadrži djelatnu tvar epoetin alfa, protein koji potiče koštanu srž da proizvodi više crvenih krvnih stanica koje sadrže hemoglobin (tvar koja prenosi kisik).
Binocrit does not normally react with other medicines but please tell your doctor if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription.
Binocrit obično ne reagira s drugim lijekovima, ali molimo obavijestite svog liječnika ako uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove – uključujući lijekove koje ste nabavili bez recepta.
Binocrit is a biosimilar medicinal product.
Binocrit je biosličan lijek.
Binocrit is a solution for injection.
Binocrit je otopina za injekciju.
Binocrit is a ‘biosimilar’ medicine.
Binocrit je „biosličan” lijek.
Binocrit is given as an injection into a vein or as an injection under the skin, depending on the condition for which the patient is being treated.
Binocrit se daje kao injekcija u venu ili injekcija pod kožu, ovisno o stanju za koje se bolesnika liječi.
Binocrit is given by injection into a vein immediately after you have donated blood for 3 weeks before your surgery.
Binocrit se daje injekcijom u venu, odmah nakon što ste donirali krv tijekom 3 tjedna prije operacije.
Binocrit is given by injection under the skin each week for three weeks before surgery and on the day of surgery.
Binocrit se daje injekcijom pod kožu svaki tjedan tijekom tri tjedna prije kirurškog zahvata i na sam dan kirurškog zahvata.
Binocrit is given by injection under the skin.
Binocrit se daje injekcijom pod kožu.
Binocrit is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):
Binocrit je indiciran za liječenje simptomatske anemije povezane s kroničnim zatajenjem bubrega (KZB):
Binocrit is indicated in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient’s general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.
Binocrit je indiciran u odraslih koji primaju kemoterapiju zbog solidnih tumora, malignog limfoma ili multiplog mijeloma, te kod kojih postoji rizik od transfuzije prema procjeni njihovog općeg stanja (npr. kardiovaskularni status, anemija koja je prisutna na početku kemoterapije), za liječenje anemije i smanjenje potrebe za transfuzijom.
Binocrit is presented as a clear, colourless solution for injection in a pre-filled syringe.
Binocrit je dostupan u obliku bistre, bezbojne otopine za injekciju u napunjenoj štrcaljki.
Binocrit is used for the following:
Binocrit se koristi za sljedeće:
Binocrit may not be suitable for you.
Binocrit možda nije pogodan za Vas.
Binocrit must not be used in the following groups:
Binocrit se ne smije koristiti u sljedećih grupa bolesnika:
Binocrit should be administered in order to increase haemoglobin to not greater than 12 g/dl (7.5 mmol/l).
Binocrit treba primjenjivati kako bi se hemoglobin povisio na razinu koja nije viša od 12 g/dl (7,5 mmol/l).
Binocrit should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dl (6.2 mmol/l)).
Binocrit treba primijeniti u bolesnika s anemijom (npr. koncentracija hemoglobina ≤ 10 g/dl (6,2 mmol/l)).
Binocrit should not be used and discarded
Binocrit se ne smije primijeniti i mora se baciti
Binocrit was as effective as Eprex/Erypo in increasing and maintaining red blood cell counts.
Binocrit je bio podjednako djelotvoran kao Eprex/Erypo u povećanju i održavanju broja crvenih krvnih stanica.
Binocrit was studied to show that it is comparable to the reference medicine, Eprex/Erypo.
Binocrit je ispitivan radi dokazivanja njegove usporedivosti s referentnim lijekom, Eprex/Erypo.
Binocrit, injected into a vein, was compared with the reference medicine in one main study involving 479 patients with anaemia caused by kidney problems.
Binocrit ubrizgan u venu uspoređen je s referentnim lijekom u jednom glavnom ispitivanju, koje je obuhvatilo 479 bolesnika s anemijom uzrokovanom problemima s bubrezima.
Bio Set system
Bio-Set sustav
BIO-SET PRESENTATION
BIO-SET PAKIRANJE
Bioavailability (AUC and Cmax) is comparable for Adempas administered orally as a crushed tablet suspended in applesauce or in water compared to a whole tablet (see section 4.2).
Bioraspoloživost (AUC i Cmax) za Adempas primijenjen peroralno u obliku zdrobljene tablete pomiješane s kašom od jabuka ili vodom usporediva je s bioraspoloživosti pri primjeni cijele tablete (vidjeti dio 4.2).
Bioavailability (AUC and Cmax) was comparable for 20 mg rivaroxaban administered orally as a crushed tablet mixed in apple puree, or suspended in water and administered via a gastric tube followed by a liquid meal, compared to a whole tablet.
Bioraspoloživost (AUC i Cmax) je bila usporediva za 20 mg rivaroksabana primijenjenog peroralno u obliku zdrobljene tablete umiješane u kašu od jabuke ili suspendiranog u vodi i primijenjenog putem želučane sonde nakon čega je uslijedio tekući obrok, u usporedbi s cijelom tabletom.
Bioavailability and absorption
Bioraspoloživost i apsorpcija
Bioavailability and pharmacokinetics of ibandronic acid are similar in both men and women.
Bioraspoloživost i farmakokinetička svojstva ibandronatne kiseline su slični u žena i muškaraca.
Bioavailability and pharmacokinetics of ibandronic acid are similar in men and women.
Bioraspoloživost i farmakokinetička svojstva ibandronatne kiseline slični su u žena i muškaraca.
Bioavailability of dolutegravir depends on meal content: low, moderate, and high fat meals increased dolutegravir AUC(0-) by 33%, 41%, and 66%, increased Cmax by 46%, 52%, and 67%, prolonged Tmax to 3, 4, and 5 hours from 2 hours under fasted conditions, respectively.
Bioraspoloživost dolutegravira ovisi o sadržaju obroka: obroci s niskim, umjerenim odnosno visokim udjelom masnoća povećali su AUC(0-) dolutegravira za 33%, 41% odnosno 66%, Cmax za 46%, 52% odnosno 67% te produljili Tmax na 3, 4 odnosno 5 sati u odnosu na Tmax od 2 sata zabilježen kod primjene lijeka natašte.
Bioavailability was reduced by approximately 75% when Bondronat tablets were administered 2 hours after a standard meal.
Bioraspoloživost se smanjuje za otprilike 75% ako se tablete lijeka Bondronat uzimaju dva sata nakon standardnog obroka.
Bioavailability was reduced by approximately 75% when Iasibon tablets were administered 2 hours after a standard meal.
Bioraspoloživost se smanjuje za otprilike 75% ako se tablete lijeka Iasibon uzimaju dva sata nakon standardnog obroka.
Bioavailability was reduced by approximately 75% when ibandronic acid tablets were administered 2 hours after a standard meal.
Bioraspoloživost se smanjuje za otprilike 75 % ako se tablete ibandronatne kiseline uzimaju 2 sata nakon standardnog obroka.
Bioavailability was reduced by approximately 75% when ibandronic acid tablets were administered 2 hours after a standard meal.
Bioraspoloživost se smanjuje za otprilike 75% ako se tablete Ibandronatne kiseline Teva uzimaju dva sata nakon standardnog obroka.
Biochemical and metabolic laboratory test abnormalities
Poremećaji rezultata biokemijskih i metaboličkih laboratorijskih testova
Biochemiestrasse 10 AT-6250 Kundl Austria
Biochemiestrasse 10 AT-6250 Kundl Austrija
Biochemistry parameters
Biokemijski parametri
Biocodex, 7 Avenue Gallieni, 94250 Gentilly, France.
Biocodex, 7 Avenue Gallieni, 94250 Gentilly, Francuska.
Biodex 150-001 Red Strips
Biodex 150-001 crvene trakice
Bioequivalence boundary 80%-125%
Granica bioekvivalencije 80%-125
Bioequivalence of Glubrava with co-administered pioglitazone and metformin has also been demonstrated (see section 5.2).
Pokazana je i bioekvivalencija lijeka Glubrava s istovremeno primijenjenima pioglitazonom i metforminom (vidjeti dio 5.2).
Bioequivalence studies have shown that vardenafil 10 mg orodispersible tablet is not bioequivalent to vardenafil 10 mg film-coated tablet; therefore, the orodispersible formulation should not be used as an equivalent to vardenafil 10 mg film-coated tablets.
Ispitivanja bioekvivalencije pokazala su da vardenafil 10 mg raspadljive tablete za usta nisu bioekvivalentne vardenafil 10 mg filmom obloženim tabletama; stoga se oblik raspadljivih tableta za usta ne smije koristiti kao ekvivalent vardenafil 10 mg filmom obloženim tabletama.
Bioequivalence studies have shown that vardenafil 10 mg orodispersible tablet is not bioequivalent to vardenafil 10 mg film-coated tablets; therefore, the orodispersible formulation should not be used as an equivalent to vardenafil 10 mg film-coated tablets.
Ispitivanja bioekvivalencije pokazala su da vardenafil 10 mg raspadljive tablete za usta nisu bioekvivalentne vardenafil 10 mg filmom obloženim tabletama; stoga se oblik raspadljivih tableta za usta ne smije koristiti kao ekvivalent vardenafil 10 mg filmom obloženim tabletama.
Bioequivalence studies in healthy volunteers have shown Glubrava to be bioequivalent to the administration of pioglitazone and metformin given as separate tablets.
Ispitivanja bioekvivalencije u zdravih dobrovoljaca pokazala su da je Glubrava bioekvivalentan primjeni pioglitazona i metformina kad se daju kao zasebne tablete.
Bioequivalence/Equivalence boundary 80-125%.
Granica bioekvivalencija/ekvivalencije 80 %-125 %.
Bioequivalence/Equivalence boundary 80-125%.
Granica bioekvivalencija/ekvivalencije od 80 % do 125 %.
Biogen (Denmark) Manufacturing ApS, Biogen Allé 1, DK-3400 Hillerød, Denmark.
Biogen (Denmark) Manufacturing ApS, Biogen Allé 1, DK-3400 Hillerød, Danska.
Biogen (Denmark) Manufacturing ApS, Biogen Allé 1, DK-3400 Hillerød, Denmark.
Biogen Denmark Manufacturing ApS, Biogen Allé 1, DK-3400 Hillerød, Danska.
Biogen Idec Limited (UK) Τηλ: + 30 211 176 8555
Biogen Idec Limited (UK)
Biogen Idec Limited, Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, United Kingdom.
Biogen Idec Limited, Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, Ujedinjeno Kraljevstvo.
Biogen Inc., 250 Binney Street, Cambridge, Massachusetts 02142, USA.
Biogen Inc., 250 Binney Street, Cambridge, Massachusetts 02142, SAD
Biogen Inc., 5000 Davis Drive, POB 14627, Research Triangle Park, North Carolina, 27709, USA.
Biogen Inc., 5000 Davis Drive, POB 14627, Research Triangle Park, North Carolina, 27709, SAD.
Bioglan AB, Borrgatan 31, SE-211 24 Malmö, Sweden
Bioglan AB, Borrgatan 31, SE-211 24 Malmö, Švedska
Biograstim 30 MIU/0.5 mL solution for injection or infusion
Biograstim 30 MIU/0,5 ml otopina za injekciju ili infuziju
Biograstim 30 MIU/0.5 mL solution for injection or infusion Biograstim 48 MIU/0.8 mL solution for injection or infusion
Biograstim 30 MIU/0,5 ml otopina za injekciju ili infuziju Biograstim 48 MIU/0,8 ml otopina za injekciju ili infuziju
Biograstim 48 MIU/0.8 mL solution for injection or infusion
Biograstim 48 MIU /0,8 ml otopina za injekciju ili infuziju
Biograstim and neutropenia in patients with HIV infection
Biograstim i neutropenija u bolesnika s HIV-infekcijom
Biograstim and peripheral blood stem cell mobilisation
Biograstim i mobilizacija matičnih stanica periferne krvi
Biograstim does not contain any preservative.
Biograstim ne sadržava konzervanse.
Biograstim is indicated for the mobilisation of peripheral blood progenitor cells (PBPC).
Biograstim je indiciran i za mobilizaciju progenitorskih stanica periferne krvi (PBPC).
Biograstim is useful in several different conditions, which are:
Primjena lijeka Biograstim korisna je u nekoliko različitih situacija, kao što su:
Biograstim should not be diluted with sodium chloride solution.
Biograstim se ne smije razrjeđivati otopinom natrijeva klorida.
Biologic Use
Primjena bioloških lijekova